Future research should be geared toward elucidating the underlying molecular mechanisms of the p38 MAPK signaling pathway in COPD pathogenesis and designing effective p38 inhibitors to alleviate chronic inflammation in bronchial and alveolar epithelial cells. Here, MAPK1 is linked to chronic obstructive pulmonary disease.